• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定 SARS-CoV-2 非感染状态——简要概述。

Determining SARS-CoV-2 non-infectivity state-A brief overview.

机构信息

Department of Immunology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.

Department of Medicine, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

出版信息

Front Public Health. 2022 Aug 12;10:934242. doi: 10.3389/fpubh.2022.934242. eCollection 2022.

DOI:10.3389/fpubh.2022.934242
PMID:36033758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412020/
Abstract

From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2.

摘要

自 COVID-19 大流行开始以来,它已导致超过 600 万人死亡,并且在全球范围内,大流行仍在肆虐,造成了新的更具传染性和可能更具毒性的变异。这场战斗中的一个临床障碍是确定感染个体何时达到非传染性状态。严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)可以在不同情况下传播,并且已经应用了各种规则和法规以及不同的测试方法来试图限制传播。然而,事实证明这是一项艰巨的任务。在这篇综述中,我们综合了最近发表的关于 SARS-CoV-2 传染性和传播性的数据,并结合了冰岛医生从大流行中积累的临床经验。此外,我们根据临床经验、科学数据和熟练使用现有测试的方法,提出了确定 COVID-19 患者何时达到非传染性状态的指南。这篇综述解决了一些关于 SARS-CoV-2 传染性和免疫力的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd5/9412020/e5ddc200748f/fpubh-10-934242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd5/9412020/e5ddc200748f/fpubh-10-934242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfd5/9412020/e5ddc200748f/fpubh-10-934242-g0001.jpg

相似文献

1
Determining SARS-CoV-2 non-infectivity state-A brief overview.确定 SARS-CoV-2 非感染状态——简要概述。
Front Public Health. 2022 Aug 12;10:934242. doi: 10.3389/fpubh.2022.934242. eCollection 2022.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.2019 冠状病毒病(COVID-19)大流行与妊娠。
Am J Obstet Gynecol. 2020 Jun;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021. Epub 2020 Mar 23.
4
Outbreak of COVID-19: A Detailed Overview and Its Consequences.COVID-19 疫情爆发:详细概述及其后果。
Adv Exp Med Biol. 2021;1353:23-45. doi: 10.1007/978-3-030-85113-2_2.
5
Clinical trials and the COVID-19 pandemic.临床试验与新冠疫情
Hell J Nucl Med. 2020 Jan-Apr;23(1):4-5. doi: 10.1967/s002449912014.
6
Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.新冠疫情期间儿童和成人通过气溶胶传播 SARS-CoV-2。
Pediatr Pulmonol. 2021 Jun;56(6):1389-1394. doi: 10.1002/ppul.25330. Epub 2021 Mar 15.
7
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.一种评估 SARS-CoV-2 感染性的体外模型,通过定义病毒分离与定量 PCR 值之间的相关性:从咽拭子中分离 SARS-CoV-2 的成功率与 Cq 值呈负相关。
Virol J. 2021 Apr 7;18(1):71. doi: 10.1186/s12985-021-01542-y.
8
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review.经输血传播严重急性呼吸综合征冠状病毒 2 的风险:文献综述。
Transfusion. 2020 Dec;60(12):3046-3054. doi: 10.1111/trf.16056. Epub 2020 Sep 1.
9
Nanotechnology-based strategies against SARS-CoV-2 variants.基于纳米技术对抗新冠病毒变异株的策略。
Nat Nanotechnol. 2022 Oct;17(10):1027-1037. doi: 10.1038/s41565-022-01174-5. Epub 2022 Aug 18.
10
The Laboratory Diagnosis of Coronavirus Disease 2019- Frequently Asked Questions.新型冠状病毒肺炎实验室检测FAQ
Clin Infect Dis. 2020 Dec 31;71(11):2996-3001. doi: 10.1093/cid/ciaa742.

本文引用的文献

1
Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.第四剂 BNT162b2 接种与长期护理机构居民感染奥密克戎和 COVID-19 住院的关联。
JAMA Intern Med. 2022 Aug 1;182(8):859-867. doi: 10.1001/jamainternmed.2022.2658.
2
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.SARS-CoV-2 BA.1 变异株被疫苗加强针诱导的血清中和,但逃避了大多数恢复期血清和治疗性抗体。
Sci Transl Med. 2022 May 18;14(645):eabn8543. doi: 10.1126/scitranslmed.abn8543.
3
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function.
选择分析鉴定出奥密克戎变异株 BA.1 中可能影响刺突功能的不寻常突变簇。
Mol Biol Evol. 2022 Apr 11;39(4). doi: 10.1093/molbev/msac061.
4
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.新冠病毒mRNA疫苗第四剂对奥密克戎毒株的效力
N Engl J Med. 2022 Apr 7;386(14):1377-1380. doi: 10.1056/NEJMc2202542. Epub 2022 Mar 16.
5
Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan.日本未接种疫苗的2019冠状病毒病德尔塔变异株患者的潜伏期较短。
Int J Environ Res Public Health. 2022 Jan 20;19(3):1127. doi: 10.3390/ijerph19031127.
6
Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021.与德尔塔变异株相比,奥密克戎 BA.1 变异株引起的 SARS-CoV-2 病例的连续间隔时间更短,荷兰,2021 年 12 月 13 日至 26 日。
Euro Surveill. 2022 Feb;27(6). doi: 10.2807/1560-7917.ES.2022.27.6.2200042.
7
Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)新病毒基因型对疫苗和抗病毒治疗潜在影响的亮点。
Gene Rep. 2022 Mar;26:101537. doi: 10.1016/j.genrep.2022.101537. Epub 2022 Feb 2.
8
A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein.基于刺突糖蛋白的 SARS-CoV-2 新兴变异株的进化综述
Int Immunopharmacol. 2022 Apr;105:108565. doi: 10.1016/j.intimp.2022.108565. Epub 2022 Jan 29.
9
The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的变异及当前疫苗的前沿研究
Front Med (Lausanne). 2022 Jan 18;8:806641. doi: 10.3389/fmed.2021.806641. eCollection 2021.
10
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.mRNA-1273加强疫苗接种后对SARS-CoV-2奥密克戎变体的中和作用。
N Engl J Med. 2022 Mar 17;386(11):1088-1091. doi: 10.1056/NEJMc2119912. Epub 2022 Jan 26.